uPA and uPAR contribute to NK cell invasion through the extracellular matrix

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1697-1704

  Al Atrash, G ^a   Kitson, R P ^a   Xue, Y ^a   Mazar, A P ^a   Kim, M H ^a   Goldfarb, R H ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Basement membrane; Natural killer cells; Plasminogen activator; Tumor infiltration; Urokinase

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ADOPTIVE TRANSFER; ARTICLE; BASEMENT MEMBRANE; CELL INFILTRATION; CELL INVASION; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING; ZYMOGRAPHY;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; APROTININ; BLOTTING, WESTERN; CASEINS; CELL MEMBRANE; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; HUMANS; KILLER CELLS, NATURAL; LAMININ; MICE; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; PHENOTYPE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PLASMINOGEN; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; U937 CELLS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034897311     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Characteristics of natural killer cells and possible mechanisms for their cytotoxic activity
2. An analysis of the murine NK cell as to structure, function and biological relevance
3. Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen
4. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
5. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
6. Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic
7. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes
8. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
9. Generation and characterization of purified adherent lymphokine-activated killer cells in mice
10. Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer
11. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2
12. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo
13. Observations on the systemic administration of autologous lymphokine- activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
14. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells
15. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets
16. Evidence that induction and regulation of lymphokine-activated killer (LAK) activity are mediated by changes in tumour-binding potential of lymphocytes after activation by interleukin-2 (IL-2)
17. Natural killer cell-target cell interactions
18. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats
19. Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: Implications for the mechanism behind anti-tumor responses
20. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells - Role in metastasis
21. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
22. Urokinase-type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix
23. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development
24. Plasminogen activator in the bursa of Fabricius: Correlations with morphogenetic remodeling and cell migrations
25. Plasminogen activators, tissue degradation, and cancer
26. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation
27. Urokinase induces receptor mediated brain tumor cell migration and invasion
28. The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis
29. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
30. Proteolytic enzymes in cancer invasion and metastasis
31. Identification and localization of urokinase-type plasminogen activator in human NK-cells
32. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase- type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface
33. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein
34. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes
35. Autocrine saturation of pro-urokinase receptors on human A431 cells
36. Characterization of the cellular binding site for the urokinase-type plasminogen activator
37. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants
38. Production of plasminogen activator by human natural killer cells. Large granular lymphocytes
39. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases
40. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes
41. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells
42. The urokinase-type plasminogen activator system in cancer metastasis: A review
43. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils
44. Matrix metalloproteinases produced by rat IL-2 activated natural killer cells
45. Cooperation of urokinase plasminogen activator and matrix metalloproteinases in NK cell invasion
46. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma
47. Leukocyte polarization in cell migration and immune interactions
48. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization
49. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes